
The Arena
ByteDance kept 56% of its AI drug unit after HSG's $290M bet
Morning on three fronts: a Chinese super-app prices its science arm separately from the ads business, a laptop finally gets enough memory and watts to argue about 300-billion-parameter models, and China starts asking what school is for when translation is free. ByteDance has closed a $290 million round for Anew Labs, the Shanghai-based AI drug discovery unit it spun out of the group, at a $1.5 billion valuation, according to Reuters, which spoke to two people with knowledge of the matter. The r










